In 2003, during the SARS outbreak, an animal study (rhesus monkey) revealed that recombinant human IFN-α2b aerosol could prevent SARS-CoV infection by inhibiting virus infection and replication [190]. The gene discussed is IFNA2; the disease is severe acute respiratory syndrome.